ABSTRACT
For a considerable time, conventional wisdom has held that multinational corporations tend to centralize R&D to the home country, in the vicinity of major production units and the corporate head office. However, empirical evidence is mounting to suggest that this may no longer be so. Indeed, in many multinational companies, foreign volumes and shares of R&D expenditures seem to be rapidly increasing.
